Connect with us

Health

Proposed GMO Mosquitoes: Africans Advised To Be Wary Of WHO

Published

on


By Chinasa Obidi

Kenyan Dr Wahome Ngare, the founding Director of Mercy Health Services, Nairobi, Kenya, has advised Africans to be wary of the World Health Organisation, WHO’s proposed introduction of GMO mosquitoes into Africa to eradicate malaria, as well as the malaria vaccine which he says will be made compulsory.”

But malaria is a treatable disease which we have been using our herbal teas to treat, plus we are unaware of the risks such GMO mosquitoes would bring,” he said, calling on Africans to exercise caution in this regard.


He said that while the  WHO has done a lot of good things for the continent, it has equally done things that have affected Africa and Africans negatively making him advice African countries to exercise caution.He expressed this warning while addressing Ugandan President, Yoweri Kaguta Museveni  in a trending video.

He gave his reasons for sounding the warning this: “In 2014/2015, WHO brought tetanus eradication campaign in our country; a campaign to eradicate neonatal tetanus.

“The vaccine that was used is a different type of tetanus vaccine that is fertility regulating, where they take tetanus and a hormone called Human Chorionic Conadotropin, and when you inject a woman with that vaccine, she produces antibodies against that hormone and is therefore rendered sterile. 

“So we are now seeing an increase in infertility cases amongst young couples who are certified okay when examined, but cannot get children, or couples who are losing three to five pregnancies before they are able to cary any pregnancy to term.


“We were able to expose this through a paper we published, and fortunately in 2017, WHO said Kenya is now free of neonatal tetanus and they left our country.”But they developed this vaccine in an over twenty year period of research from 1972 to 1992 and used that vaccine in South America and possibly many other African countries.

“Responding to this call, Benjamin Amodu, a professor of Phytho-medicine from the Triune Biblical University, USA, who has been at the forefront of advocating for the use of herbal medicine, said Nigerians and Indeed Africans should also evaluate and verify any treatment or vaccine that is given to them before going ahead to use them.

“I think this is a very common view all around . I think we can cooperate with the WHO in most of the things and we can also evaluate to see that is in line with our own aspiration as a country just like the Ugandan and Kenyan  doctors did to their president.

“It is a welcome development. We should ensure that whatever is being brought upon us  should be well evaluated to see and if there are  needs for modification, they should be modified to the interest of who they are introducing the the programme to.

” Even their comment on malaria, I think the WHO should be more open.  Irrespective of where whatever treatment or vaccine is coming from, so long as it meets the requirements should be accepted and adopted so we move forward.

“I therefore call on African leaders and people to exercise faith in our God given natural herbs , carry out extensive research and promote it because even diseases for which the cures have eluded modern medicine for decades are being effectively cured with the use of Traditional, Complimentary and Herbal Medicines, TCAM, without any side effects.” 

It would be recalled that Prof Amodu’s malaria cure was evaluated by the United Nations and found to be more effective than chloroquine and palaudrine.

Continue Reading

Health

New Malaria Plan Puts States, Local Data At Centre Of Nigeria’s 2030 Response

Published

on

Cyril Ogar

Nigeria’s latest malaria data point to a country making progress overall but facing sharply different disease burdens from one state to another, prompting health authorities to shift emphasis towards locally tailored interventions under a new five-year strategy.

The National Malaria Strategic Plan (NMSP) 2026–2030, launched alongside the 2025 Nigeria Malaria Indicator Survey (NMIS) report, seeks to cut malaria parasite prevalence and deaths by 50 per cent from 2025 levels by 2030.

Rather than applying a uniform national response, the plan prioritises interventions based on local epidemiological evidence, while also calling for stronger domestic financing, improved diagnosis and treatment, better surveillance and clearer accountability.

The Coordinating Minister of Health and Social Welfare, Prof. Muhammad Ali Pate, represented by the ministry’s Permanent Secretary, Mrs Daju Kachallom, presented the government’s position at the joint launch in Abuja.

Pate described the survey and strategic plan as essential tools for identifying weaknesses in malaria control and directing resources towards areas with the greatest need.

He said the survey’s findings on prevalence, prevention, diagnosis and treatment would support policy development, programme implementation, resource allocation and performance assessment.

The minister said the strategic plan was designed to accelerate progress towards a malaria-free Nigeria while remaining consistent with national health priorities and the World Health Organisation’s global malaria strategy.

He commended the National Malaria Elimination Programme (NMEP), the National Population Commission (NPC), development partners and other stakeholders involved in producing the survey and plan.

Pate also called for a shared national effort involving federal and state governments, the private sector, communities and households, stressing that malaria elimination could not be achieved by government alone.

The 2025 NMIS shows that malaria parasite prevalence among children aged six to 59 months, measured through microscopy, fell from 42 per cent in 2010 to 23 per cent in 2018, 22 per cent in 2021 and 15 per cent in 2025.

However, the national improvement masks substantial differences between states. Prevalence among children in the same age group ranged from two per cent in Lagos State to 31 per cent in Ebonyi State.

The figures indicate that progress has not been evenly distributed and that malaria control efforts must be adapted to the conditions in individual states and communities.

Earlier, the National Coordinator of NMEP, Dr Nnenna Ogbulafor, said the NMSP was developed from the 2025 NMIS findings and other programme data.

She said the evidence would help policymakers locate high-burden areas, improve the design of interventions and direct limited resources to communities most in need.

Ogbulafor said the plan was aligned with Nigeria’s health sector priorities and the WHO Global Technical Strategy for Malaria 2016–2030.

She identified policy alignment, state-level leadership, domestic financing, partnerships and accountability as central to implementation.

The national coordinator urged state governments, civil society organisations and development partners to take ownership of the plan and support coordinated, adequately funded malaria programmes.

She said the differences in prevalence across states made subnational planning indispensable to meeting the national targets.

Ogbulafor called on states to develop comprehensive malaria control programmes reflecting local disease burdens, epidemiological evidence and available resources.

She also stressed the need for sustained domestic financing and partnerships to close funding gaps and maintain implementation through 2030.

NMEP, she said, would work with the National Malaria Working Group and international partners to track implementation, assess performance and review results regularly.

The plan aims to raise access to and use of preventive interventions to at least 80 per cent, achieve at least 90 per cent effective coverage of malaria diagnosis and appropriate treatment among at-risk populations, and improve surveillance performance from a baseline of 47 per cent to 70 per cent by 2030.

It also targets stronger governance and organisational capacity, with at least 60 per cent of malaria programme resources expected to come from domestic sources by 2030.

The survey data show that prevention remains uneven. Only 54 per cent of households had at least one insecticide-treated net, while 45 per cent of children under five and 54 per cent of pregnant women aged 15–49 slept under a net on the night before the survey.

Protection during pregnancy was also incomplete. Among women aged 15–49 who had a live birth in the preceding two years, 62 per cent received at least one dose of sulphadoxine-pyrimethamine during their last pregnancy, but only 33 per cent received three or more doses.

The findings point to the need to expand access to insecticide-treated nets and intermittent preventive treatment for pregnant women.

Diagnosis is another major gap. Of children under five who had a fever in the two weeks before the survey, 59 per cent had advice or treatment sought, but only 18 per cent had blood taken for malaria testing.

The strategic plan therefore places emphasis on prompt testing, appropriate treatment, preventive services and public awareness.

In his remarks, the Director-General of NPC, Dr Abubakar Muhammed, pledged the commission’s continued support for credible demographic and health data to guide policymaking and malaria elimination efforts.

Muhammed said the survey reflected the partnership between the Federal Ministry of Health and Social Welfare, through NMEP, and the NPC.

He said the collaboration brought together expertise in malaria control, demographic surveys and data management to produce information for national planning and development.

The NPC director-general said the commission would continue to modernise its survey operations through technologies such as the Global Positioning System (GPS) and spatial techniques.

He urged policymakers, programme managers, researchers and development partners to use the findings to refine strategies, improve implementation and target communities where interventions were most needed.

Muhammed commended the ministry, NMEP, technical consultants, state enumerators and field teams for their roles in conducting the survey.

He said the report would provide a strong evidence base for a coordinated national malaria response.

The launch of the NMIS report and NMSP 2026–2030 places the next phase of Nigeria’s malaria response on a clearer understanding of where the disease remains most entrenched, while challenging states and partners to convert that evidence into measurable local action.

Continue Reading

Trending

error

Enjoy this blog? Please spread the word :)